Disc Medicine IRON
NASDAQ IRON
$79.23 -0.14 (-0.18%)
As of: Sep 4, 2026 · 3:59 PM EDT

Disc Medicine (IRON) Other Working Capital Changes (2020 - 2026)

Disc Medicine (IRON) posted quarterly Other Working Capital Changes of -$174000.0 for Q2 2026, down 341.67% year-over-year from $72000.0 in Q2 2025, and down 3.57% quarter-over-quarter from -$168000.0 in Q1 2026.

Analysis

Disc Medicine (IRON) Other Working Capital Changes (2020 - 2026) Analysis & Trends

Disc Medicine (IRON) has reported Other Working Capital Changes for 5 consecutive years, with -$174000.0 the latest figure, recorded in Q2 2026.

  • In Q2 2026, Other Working Capital Changes fell 341.67% year-over-year to -$174000.0; the TTM figure through Jun 2026 stood at -$663000.0 (down 340.22% YoY), while the FY2025 annual figure was $186000.0, up 137.58% from the prior year.
  • Other Working Capital Changes fell to -$174000.0 in Q2 2026 per IRON's latest filing, from -$168000.0 in the prior quarter.
  • Across five years, Other Working Capital Changes topped out at $7.2 million in Q1 2025 and bottomed at -$3.2 million in Q1 2022.
  • Historically, Other Working Capital Changes has averaged $579388.9 across 5 years, with a median of -$192000.0 in 2022.
  • Annual changes were most pronounced in 2023 — Other Working Capital Changes plunged 476.47% — and 2025, when it surged 680.0%.
  • Disc Medicine's Other Working Capital Changes stood at -$73000.0 in 2022, then surged by 146.58% to $34000.0 in 2023, then plunged by 423.53% to -$110000.0 in 2024, then slumped by 50.0% to -$165000.0 in 2025, then fell by 5.45% to -$174000.0 in 2026.
  • Business Quant data shows IRON's Other Working Capital Changes at -$174000.0 in Q2 2026, -$168000.0 in Q1 2026, and -$165000.0 in Q4 2025.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn -
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn -
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn
10 Disc Medicine 3.06 Bn 3.06 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 -2.28 Mn
Jun 30, 2026 -2.28 Mn
Mar 31, 2026 4.55 Mn
Mar 31, 2026 4.55 Mn
Dec 31, 2025 1.38 Mn
Dec 31, 2025 1.38 Mn
Sep 30, 2025 -371,000.00
Sep 30, 2025 -371,000.00
Jun 30, 2025 681,000.00
Jun 30, 2025 681,000.00
Mar 31, 2025 7.23 Mn
Mar 31, 2025 7.23 Mn
Dec 31, 2024 -2.08 Mn
Dec 31, 2024 -2.08 Mn
Sep 30, 2024 -1.11 Mn
Sep 30, 2024 -1.11 Mn
Jun 30, 2024 -2.50 Mn
Jun 30, 2024 -2.50 Mn
Mar 31, 2024 4.11 Mn
Mar 31, 2024 4.11 Mn